BackVirpax Pharmaceuticals Overview

Virpax Pharmaceuticals Current Cash

Virpax Pharmaceuticals's current cash is $1.5M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$1.51M
83.45% YoYΔ $-7.63M vs prior year quarter

Peer trimmed avg / median

Loading

Virpax Pharmaceuticals Current Cash History

Loading

Virpax Pharmaceuticals vs. peers: Current Cash Comparison

Loading

Virpax Pharmaceuticals Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Virpax Pharmaceuticals (VRPX) FAQ

As of the most recent data (December 2024), VRPX shows a current cash of $1.5M. That compares with $9.1M in the prior-year period — down 83.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, VRPX's current cash is now $1.5M (was $9.1M) — a 83.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Virpax Pharmaceuticals is outperforming or lagging.

Tracking VRPX's current cash over time shows whether Virpax Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $1.5M That compares with $9.1M in the prior-year period — down 83.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Virpax Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $1.5M) with ownership activity and broader fundamentals.

Virpax Pharmaceuticals's current cash is $1.5M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.